Lazard Closes Campbell Lutyens Deal, Issues 9.65M Shares Plus $93.2M Cash
LAZ is trading near its 52-week low of $34.13 (12% above the low).
Summary
Lazard completed its Campbell Lutyens acquisition, paying 9,651,777 shares at a $46.50 reference price plus about $93.2 million cash, with $115 million deferred and up to $85 million in earn-out. Sellers received resale registration rights on the stock.
Key Events · M&A and Partnerships · LAZ
-
Campbell Lutyens Acquisition Closes
Lazard completed the purchase of 100% of Campbell Lutyens on November 1, 2026 and launched the combined private capital advisory unit as Lazard CL.
-
Consideration: 9.65M Shares Plus $93.2M Cash
Initial consideration was 9,651,777 shares issued at a $46.50 reference price plus approximately $93.2 million in cash, with $115 million deferred to the second anniversary and up to $85 million of earn-out through 2030.
-
Resale Registration Rights Granted
Sellers can demand shelf underwritten offerings once lock-ups lapse if they expect gross proceeds above $80 million, capped at four offerings total and one per 120 days; the share issuance is capped at 19.99% under NYSE rules.
-
Revenue Target Reiterated
Lazard continues to expect Lazard CL to generate approximately $500 million of combined revenue and be accretive to earnings in 2027 before synergies.
Analysis · LAZ · Finance
The acquisition Lazard announced on April 30, 2026 is now closed, and this filing puts hard numbers on the price for the first time: 9,651,777 shares issued at a $46.50 reference price plus about $93.2 million of cash up front, with $115 million deferred to the second anniversary and up to $85 million more in earn-out through 2030. The share count is roughly 8.5% of the 113.6 million shares implied by today's $38.35 price and $3.75 billion market value, and the sellers get resale registration rights, so a tradable overhang builds as lock-ups of up to three years roll off. Management reiterated that Lazard CL should produce about $500 million of combined revenue and be accretive in 2027, which is the number that matters for whether the deal pays for itself.
How filings like this one have moved
In the 30 days to Nov 15, 2026, 37.5% of the 3713 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, LAZ was trading at $38.35 on NYSE in the Finance sector, with a market capitalization of approximately $3.7B. The 52-week trading range was $34.13 to $58.75. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.